Abstract-Investigating the physics in tumor development and progression has been recognized as a promising way to advance both basic cancer research and clinical cancer treatment. The advent of atomic force microscopy (AFM) provides an exciting multifunctional tool for investigating the physical properties of biological systems under aqueous conditions with unprecedented spatiotemporal resolution, opening new possibilities for nanomedicine in physical oncology. In this paper, the biomedical applications of AFM to investigate the physical sciences in oncology at single-cell, single-molecule, and tissue levels are systematically reviewed, taking lymphomas as an example. First, detecting the physics of cancers at multiple scales is summarized, along with antibody-based therapy for lymphomas. Next, the principles and methods of AFM imaging and measurements are summarized. After that, utilizing AFM to probe the physics of tumors is reviewed from several facets, including topographical imaging, mechanical measurement, molecular recognition, primary cell detection, and tissue characterization. In particular, the motivations and state-of-the-art overviews of each facet are presented. Finally, the current limitations and future directions of AFM assays for cancer investigations are discussed.
vessels [5] . In addition to biochemical and genetic abnormalities, cancerous cells generate and exert physical forces on their microenvironments during tumor growth to increase invasive and metastatic potential [6] . The interplay between cancerous cells and tumor niche via forces is often accompanied with the remarkable changes in the physics of tumors [7] , [8] . For example, solid tumors are significantly stiffer than healthy tissues, and thus tumors are frequently detected via physical palpation [9] . The rigidity of tumors is largely due to the stiffened extracellular matrix [6] which is caused by the remodeling of tumorassociated extracellular matrix (including extracellular matrix deposition, fiber alignment and cross-linking) [10] . On the contrary, the cancer cells inside the tumors are significantly softer than their normal counterparts [11] . The softness characteristics facilitates the migration behaviors of cancer cells, such as intravasation and extravasation [12] , which eventually promotes the metastasis of cancer cells [13] . By normalizing the physics of tumor components, such as vasculature, extracellular matrix and cancer glycocalyx [6] , clinical evidence has reported the improved survival in cancer patients [14] , [15] , showing great biomedical potential in attenuating cancers [16] . Hence, developing methods to investigate the physical cues involved in tumor development and progression is of remarkable significance for both basic cancer research and clinical cancer treatment.
A wide range of methods have been used to detect the physics of tumors at multiple scales. Conventionally, clinicians often diagnose tumors based on a change of tissue stiffness sensed by palpation [17] . For example, malignant breast tissue can be 10 times stiffer than normal breast tissue [7] . Shear wave ultrasound elastography is widely used in clinical stiffness imaging for assessing tumors [18] . Ultrasound creates two types of waves, compression wave and shear wave. The transmission of longitudinal compression wave leads to tissue displacement, which results in the propagation of shear wave that runs horizontally [19] . The propagation of shear wave is related to the stiffness of the tissue, and thus stiffness maps are produced by detecting the shear waves [20] . Another method used in clinics for detecting tumor stiffness is magnetic resonance (MR) elastography [21] which involves three main steps: generating shear waves in the tissues using an external driver, acquiring MR images depicting the propagation of the shear waves, and processing the MR images to construct quantitative images displaying the stiffness of the tissues. In 2015, Wickramaratne et al [22] present a method called fine needle elastography to detect the stiffness of tissues. A fine needle (500 μm diameter) is connected to a piezoelectric transducer, which can record the force profiles reflecting the 1536-125X © 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications standards/publications/rights/index.html for more information. AT MULTIPLE SCALES penetration process between needle and tissues under the guidance of ultrasound imaging. Recently, Liu et al [23] developed a cell-based system, based on engineered mesenchymal stem cells (MSCs), which responds specifically to mechanoenvironmental cues to target breast cancer metastases. The method is based on the principle that MSCs differentiate into different types of cells depending on matrix elasticity [24] . When MSCs encounter the tumor tissues which are stiff, specific molecules are produced, which deliver therapeutics to tumors [8] . MSCs remain inactive on healthy tissues which are soft. It should be noted that these methods described above are suited for detecting the physics of tumors at tissue-level. By applying single-cell techniques, such as atomic force microscopy (AFM), optical tweezers, and magnetic tweezers [25] , the physics of individual tumor cells can be exactly measured. Since this paper focuses on AFM, readers are referred to [26] for detailed descriptions of optical tweezers and magnetic tweezers. The advantages and limitations of the methods [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] described above are summarized in Table I .
In this article, we review the utilization of AFM to detect the physics involved in tumor development and progression (taking lymphomas as an example) from multiple scales, including cellular physics, molecular physics, and tissue physics. We highlight the related methodologies of AFM for probing the diverse physical properties of tumors, including cellular topography imaging, cellular mechanical measurement, molecular force recognition, and tissue physical characterization. In particular, the applications of AFM characterizations on clinical primary cells are presented. The current limitations are discussed and the perspectives for future directions are also provided.
II. LYMPHOMAS AND RITUXIMAB
Lymphomas are solid tumors of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are non-Hodgkin lymphoma [33] . In 2012, non-Hodgkin lymphomas accounts for about 3% of all new cases of cancers worldwide [34] . Non-Hodgkin lymphomas are cancers of B lymphocytes, T lymphocytes or natural killer lymphocytes [35] . Approximately 85% of non-Hodgkin lymphomas in adults are of B cell origin [36] . The World Health Organization (WHO) classification categories lymphomas into more than 35 distinct subtypes based on the morphology, immunophenotype, genetic alterations and clinical features [37] . Diffuse large B-cell lymphoma and follicular lymphoma are the most common B-cell lymphomas, comprising about 60% of all B-cell lymphomas [38] , [39] . Diffuse large B-cell lymphoma is biologically aggressive, but can be cured in >50% of cases with the most commonly used therapy called R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone) [40] . Follicular lymphoma is often clinically indolent initially but with a tendency for relapse [41] . While indolent lymphoma remains an incurable disease, the overall survival has been improved with the use of rituximab [42] . Evidence has shown that the interactions between neoplastic B cells and accessory stromal cells in specialized tissue microenvironments, such as the bone marrow and secondary lymphoid organs, favors disease progression by promoting malignant B-cell growth and drug resistance [43] .
The approval of rituximab in 1997 by the U.S. Food and Drug Administration (FDA) has revolutionized the molecular targeted therapy of B-cell lymphomas. Rituximab is a chimeric monoclonal antibody (incorporating human immunoglobulin G1 heavy-chain sequences and murine immunoglobulin variable regions) that binds to the CD20 antigen on B cells [41] . CD20 is a 33-37 kDa, tetra-spanning membrane protein expressed on the surface of mature B cells, including >90% of B-cell lymphomas, but is absent from stem cells, plasma cells and nonlymphoid tissue [44] . CD20 functions as an amplifier of calcium signals that The binding between rituximab and CD20 can also trigger the complement-dependent cytotoxicity (CDC). During CDC, the complement protein C1q binds to the Fc domain of rituximab, which activates the classical complement pathway. The final product of CDC is the generation of membrane attack complex (MAC) on the cell surface. Small molecules such as water molecules and ions enter into the cell freely to cause the death of the cell. In addition, rituximab is able to activate the antibody-dependent cellular cytotoxicity (ADCC). The Fc domain of rituximab binds to the Fcγ receptor (FcR) on the effector cell (such as NK cell and macrophage). NK cell releases cytotoxic granules to kill the B lymphoma cell, whereas macrophage depletes the B lymphoma cell via phagocytosis.
are transduced through the B-cell receptor during antigen recognition by B cells [45] . Though the in vivo mechanisms of rituximab are still poorly understood, rituximab achieves unprecedented success in clinical practice. The use of rituximab, particularly in combination with chemotherapy/radiotherapy regimes, has significantly improved all aspects of the survival statistics for B-cell lymphomas [46] . In vitro studies have shown that the binding of rituximab to CD20 leads to the death of B cells via three main mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and programmed cell death (PCD) [47] , as shown in Fig. 1 . The clinical success of rituximab in eradicating B lymphoma cells may due to the merits of CD20. CD20 is expressed at high levels on B cells compared with other targets, allowing dense accumulation of rituximab on the cell surface to produce efficacies [48] . Besides, CD20 is resistant to internalization after its bound to rituximab, facilitating recruiting effector cells to sustainably attack the target cells [49] . However, it should be noted that rituximab also depletes normal B cells. Studies have shown that rituximab induces almost complete depletion of normal B cells in the peripheral blood of patients, which lasts for 6-9 months [50] , [51] . The depletion of normal B cells directly leads to the decrease of plasma cells, which can cause adverse effects [41] of the patients' immune system.
Improving the efficacies of anti-CD20 antibodies will benefit the treatments of B-cell lymphomas. Despite the huge clinical success of rituximab, there are still many patients who relapse after receiving rituximab-containing immunochemotherapy and develop resistance to rituximab [52] . The current challenge is how to provide effective treatments for these rituximab-resistant patients. Studies have shown that the acute resistance of rituximab can be associated with the loss of CD20 from the cell surface [53] . Besides, the low affinity of Fcγ receptor on the effector cells weakens the ADCC mechanism, which can potentially contribute the rituximab resistance [54] . Anti-CD20 antibodies are divided into two subtypes, termed type I and type II [45] . Both type I and type II antibodies are able to engage ADCC mechanism. The differences are that type I antibodies redistribute CD20 into membrane lipid rafts and potentially activate CDC, whereas type II antibodies weakly activate CDC but more potently evoke PCD [52] . Many novel antibodies targeting CD20 have been developed [55] . Obinutuzumab is a humanized type II anti-CD20 antibody with enhanced ADCC and approved for treating chronic lymphocytic leukemia by U.S. FDA in 2013 [56] . A recent clinical study has shown that obinutuzumab plus bendamustine has efficacy in rituximab-resistant B-cell lymphoma patients [57] , providing a new treatment option for patients who are no longer responding to rituximab-based therapy. In recent years, novel strategies, such as antibody-drug conjugates, bispecific antibodies and antibody engineering to facilitate more effective delivery [58] , have been developed for designing antibodies with enhanced efficacies [59] , which will have potential impacts on antibody-based immunotherapy of cancers.
III. PRINCIPLES AND METHODS OF ATOMIC FORCE MICROSCOPY IMAGING AND MEASUREMENTS

A. AFM Imaging Modes 1) Contact and Tapping AFM:
The two most commonly used AFM imaging modes are contact mode and tapping mode. As shown in Fig. 2A , AFM uses a sharp tip mounted at the end of a soft cantilever to raster scan the specimens. The tip curvature radius, one of the most important parameters determining the spatial resolution of AFM imaging, is in the nanometer range [60] . A four-quadrant position sensitive detector (PSD) is utilized to sense the laser beam reflected from the backside of the cantilever to detect the deflection of the cantilever. The piezoelectric actuator drives the tip move vertically to maintain the constant interaction forces between tip atoms and sample surface atoms. Fig. 2B shows the changes of tip-sample interaction forces versus the tip-sample distance. By utilizing different force zones, AFM works at diverse imaging modes. Contact mode imaging is based on the repulsive forces (short range Coulomb interaction force) between tip and sample surface, while noncontact mode imaging is based on the attractive forces (van der Waals interaction forces) between tip and sample surface [61] . Contact mode uses the repulsive forces which are localized (the repulsive forces between tip atoms and target atoms on the sample are not susceptible by the neighboring atoms on the sample), facilitating AFM imaging to achieve high spatial resolution. For example, with contact mode, high-quality topography images of single native or reconstituted membrane proteins in action can be clearly obtained [62] , [63] . Besides, contact mode is widely used for living cell imaging [64] , [65] , particularly for visualizing cytoskeleton structures [66] , [67] . The drawback of contact mode is that the lateral movement of tip causes the mechanical scratch to the specimens, which is detrimental for observing soft and loosely adsorbed biological samples. Tapping mode is invented to overcome the drawback of contact mode. In tapping mode, the cantilever vibrates near its resonance frequency and the tip touches the sample at its downward movement, eliminating the friction between tip and sample. The contact between vibrating tip and sample results in the changes of the oscillation behaviors of cantilever, such as amplitude and resonance frequency. Hence, tapping mode can be achieved by either detecting the changes of cantilever's amplitude or detecting the changes of cantilever's resonance frequency [68] . Using amplitude as the feedback is technically simpler because it requires only one feedback loop compared with using frequency as feedback which requires three feedback loops [69] , [70] . Tapping mode is particularly suited for imaging the loosely adsorbed and soft samples, such as DNA [71] [72] [73] and mammalians suspended cells [74] , [75] . Compared with amplitude-modulation, the resonance frequency shift is more sensitive to the forces acting on the tip at the closest approach to the sample surface during the oscillation cycle, and frequency-modulation tapping mode is able to resolve the fine structures of single biomolecules with unprecedented spatial resolution, such as the helix structure of DNA [76] and Y-shaped structure of antibody molecules [77] . The comparison between the diverse AFM imaging modes for different biomedical applications is summarized in Table II. 2) Non-Contact AFM: Non-contact mode has been used to probe the atomically chemical structures of molecules [78] [79] [80] . For atomic imaging of molecules, specific tips are required. As shown in Fig. 2C , a CO molecule is picked up by the AFM metallic tip (often copper), with the carbon bonded to the metallic tip and the oxygen protruding outwards. Non-contact atomic imaging involves the use of low-temperature scanning tunnelling microscopy (STM)-AFM systems and qPlus sensors [78] , which allows AFM operation at oscillation amplitudes down to fractions of an angstrom. AFM images of molecules are obtained in constant-height mode, in which the tip is scanned in a fixed plane above the molecule while the frequency shift is recorded. With the use of CO-functionalized tip, the five hexagonal carbon rings of a pentacene molecule deposited on Cu substrate is clearly resolved [79] , as shown in Fig. 2C . With CO-functionalized tip, the real-space visualization of the for -TABLE II  AFM IMAGING MODES FOR DIFFERENT BIOMEDICAL APPLICATIONS mation of hydrogel bonding in 8-hydroxyquinoline molecules is also obtained [80] .
3) AFM Force Spectroscopy: AFM force spectroscopy has been used to probe the mechanical information of specimens. In the force spectroscopy mode, AFM tip vertically performs approach-retract cycle on the specimen [81] . Fig. 2D shows the schematic of a force curve recorded during the approachretract movement of AFM tip. Firstly, the AFM tip gradually approaches the specimen (denoted by a in Fig. 2D ). When the tip touches the thin water layer on the specimen in ambient environment, the capillary forces [82] cause the tip to jump to contact the specimen (denoted by b in Fig. 2D ). In aqueous conditions, the capillary forces disappear and thus no jumping to contact happens. Subsequently, AFM tip indents the specimen until the preset force exerting via the cantilever is achieved (denoted by c in Fig. 2D ). After that, AFM tip retracts from the specimen. The adhesion forces between AFM tip and specimen result in the firm adsorption of AFM tip on the specimen(denoted by d in Fig. 2D ). When the pulling force exerted on the cantilever is larger than the adhesion forces, AFM tip detaches from the specimen (denoted by e in Fig. 2D ) and returns to its original position. Based on AFM force spectroscopy, when controlling regular AFM tip (without chemical or biological functionalization) to mechanically indent and pull the biomolecules, the mechanical properties of biomolecules are measured by analyzing the recorded force curves. The force peaks in the recorded curves reflect the intramolecular interactions, such as DNA base pair unzipping [83] [84] [85] and protein unfolding [86] [87] [88] . However, this technique is limited to reconstituted or purified biomolecules, since the AFM tip is nonspecific to biomolecules and cannot distinguish different types of biomolecules according to the molecular morphology. On the cell surface, there are various types of biomolecules, and the use of functionallized tip (e.g., tips carrying specific ligands) allows recognizing and probing the specific receptors on the cell surface [89] [90] [91] . The ligands attached to the AFM tip are able to specifically bind to the cognate receptors on the cell surface to form molecular pair. By pulling the ligand out from the receptor-ligand pair with AFM cantilever, the receptor-ligand pair ruptures, which yields characteristic force changes [92] , [93] in the recorded force curves. By analyzing the force curves, the receptors on the cell surface are located [94] and the intermolecular dynamic dissociations are resolved [95] .
4) Multiparametric AFM:
In recent years, multiparametric AFM [96] , [97] has been available for simultaneously imaging the multiple physical information of samples. Multiparametric imaging is based on the peak force tapping (PFT) mode of AFM [98] . In PFT, the vibrating AFM tip indents the sample at each sampling points to record force curves. The peak force of the force curve is used as the feedback. The peak force corresponds to the force between the contact point and the maximum extension point on the y axis in the approach curve (as illustrated in Fig. 2B ). By analyzing the force curves, different physical properties (e.g., elasticity, adhesion, deformation) of the samples are visualized simultaneously with the topography of samples [70] , as shown in Fig. 2E . In conventional tapping AFM, AFM cantilever vibrates at a frequency which is near the resonant frequency of the cantilever. In PFT, the vibration frequency of cantilever is much less than the resonant frequency of the cantilever [99] . Consequently, PFT exerts smaller tapping force than conventional tapping, which is of important significance for observing fragile biological samples. Multiparametric AFM has been shown to be able to reveal the correlation between the structure, physics and functions of diverse biosystems, including molecules [100] , virus [101] , membranes [102] and cells [103] . Besides, with the use of functionalized tips, multiparametric AFM is able to rapidly map the spatial distributions of specific biomolecules on the cell surface [104] [105] [106] .
5) Multifrequency AFM: Multifrequency AFM has been developed for advancing the imaging capabilities of AFM. Conventional tapping mode AFM involves excitation and detection of a single frequency component of the tip's motion, and therefore the information about the properties of the sample that is included in the other frequency components is irreversibly lost [107] . Multifrequency AFM involves excitation and detection of the cantilever deflection at several frequencies, showing remarkable enhancement in providing complementary information of the specimens being probed [108] [109] [110] . There are different types of multifrequency AFM techniques. Multiharmonic AFM [111] records several harmonic amplitudes of the vibrating cantilever, such as the first three flexural modes (Fig. 2FI) . Bimodal AFM uses two external driving forces to excite the first two flexural cantilever modes [112] , as shown in Fig. 2FII . The output signal of the first mode is used for imaging the topography of the sample while the output signal of the second mode is used for imaging the properties of the sample. Torsional harmonic AFM (Fig. 2FIII) records the higher harmonics of the flexural and torsional signal of the cantilever [113] . T-shaped cantilever where the tip is offset from the cantilever axis is required to generate the torque around the axis of the cantilever for torsional harmonic AFM. Multifrequency AFM achieves high spatial resolution of imaging. For example, based on multifrequency imaging, chemical groups inside a protein complex has been visualized [114] and the elastic properties of heterogeneous materials have been measured in liquid with angstrom-scale spatial resolution [115] . Further, multifrequency AFM is able to visualize the interior structures of cells [107] , [116] , facilitating understanding cell behaviors.
6) High-Speed AFM: High-speed AFM has been developed for improving the temporal resolution of AFM imaging. Usually it takes a few minutes to tens of minutes for recording an AFM image of biological samples by conventional AFM, which is quite larger than the timescale at which cellular physiological activities usually occur. The advent of high-speed AFM [117] significantly reduces the time of recording an AFM image. Highspeed AFM imaging is achieved by optimizing various parts of AFM, including cantilevers, electronic circuits, scanner, and the cantilever deflection detection systems [118] . For example, cantilevers are miniaturized to achieve high resonant frequencies and the feedback control technique capable of suppressing the scanner's mechanical vibrations is required [118] . With high-speed AFM, the dynamics of molecular behaviors taking place at the millisecond scale can be visualized, such as myosin molecules (Fig. 2G ) [119] , rotary molecules [120] and clock proteins [121] , opening novel opportunities for accessing the real-time dynamics of molecular behaviors. Notably, currently high-speed AFM is mainly suited for observing biomolecules adsorbing on stiff support or microbial cells having stiff surface. Wide-area high-speed scanner has been developed for imaging living mammalian cells [122] , but the imaging speed of living mammalian cells is still relatively slow (about 10 second per frame). In order to achieve faster high-speed AFM, methods for high-sensitivity deflection detection of a tiny cantilever or a nanowire are required [123] .
7) TREC Mode AFM: Traditionally, the receptors on the cell surface are mapped by recording arrays of force curves on the cell surface with the functionalized tip, which is very time-consuming. The advent of simultaneous topography and recognition imaging (TREC) AFM [124] , [125] considerably improves the efficiency of molecular recognition. As shown in Fig. 2H , in the TREC mode, the oscillating tip (the oscillation frequency approximates the resonance frequency of cantilever) carrying ligands raster scans the cell surface. During scanning, if the ligand does not bind to the receptor, the tip vibrates like imaging with a non-functionalized tip. When the ligand binds to the receptor on the cell surface, the subsequent unbinding of receptor-ligand pair causes the changes of the upper part of the vibration amplitude signal but does not influence the lower part of the vibration amplitude signal. By using a special electronic circuit called TREC box, the recognition image is constructed simultaneously with topography image [126] , [127] . TREC AFM allows that the time of recording molecular recognition image on the cell surface is comparable to that of recording an image by conventional AFM imaging and also facilitates directly understanding the structure and molecular recognition on cell surface. Notably, TREC does not record force curves during imaging, and thus quantitative force information about molecular binding events is missing [70] .
B. AFM Cellular Measurements
1) Single-Cell Mechanical Indentation: AFM tip vertically performs approach-dwell-retract cycles on the cell surface to probe cellular mechanical properties. As shown in Fig. 3A , firstly, the AFM probe, which is far away from cells, is controlled by the piezoelectric driver to gradually approach and indent the cells in the vertical direction. The indentation process between tip and cell results in the deflection of AFM cantilever x which is detected by the PSD of AFM. According to the Hooke's law:
where k is the spring constant of the cantilever and x is the deflection of the cantilever, the loading force F exerting on the cantilever is obtained. In order to exactly obtain the loading force exerted by the cantilever, the spring constant of the cantilever needs to be accurately calibrated in advance. Diverse methods have been developed for calibrating the spring constant of cantilever [128] , including static mass hanging method, reference cantilever method, dynamic mass attachment method, resonant frequency method, and thermal noise method. In practice, force curves are obtained on the stiff substrate to calibrate the deflection sensitivity of the cantilever, and then the spring constant of the cantilever is calibrated by the thermal noise [129] module of AFM. When the loading force achieves the preset value, AFM probe stops indenting and dwells on the cell surface for a period of time. Finally AFM probe retracts from cell surface to the original position. During the approach-dwellretract process, the displacement changes of AFM driver and the deflections of AFM cantilever are recorded by AFM, which yield the force-distance (F-D) curves [130] , as shown in Fig. 3B . Each force curve is composed of two portions, approach curve and retract curve. Due to the dwelling of AFM tip on cell surface, the end point of the approach curve does not coincide with the start point of the retract curve. Generally, the approach curve is used for analyzing the cellular elastic properties [131] , whereas the retract curve is used for revealing molecular mechanics (e.g., protein unfolding, molecular binding and cellular adhesion [91] ) which usually requires using biochemical sensitive tips. By linking an oscilloscope to the output signal of AFM [130], the PSD signal changes of AFM cantilever versus time are recorded, which yield the force-time (F-T) curves. The F-T curves obtained during the dwelling process of AFM tip on cells reflect the relaxation dynamics of cells, as shown in Fig. 3C . By analyzing the F-T curves, cellular viscoelastic properties are obtained [132] .
2) Measurement of Cellular Elasticity: Cellular Young's modulus is acquired by analyzing the F-D curves obtained on cells. Several theoretical models have been presented for analyzing the indentation process of AFM tip, such as Hertz-Sneddon, Johnson-Kendall-Roberts (JKR), Derjaguin-Muller-Toporov (DMT), and Oliver-Pharr [31] , [133] . Hertz-Sneddon model neglects the adhesion forces between AFM tip and cell, while JKR and DMT model consider the adhesion forces between AFM tip and cell [61] . Oliver-Pharr model is mainly used for determining the mechanical properties of thin films [134] . In practice, Hertz-Sneddon model is the most widely used model for calculating cellular Young's modulus from F-D curves [135] [136] [137] . Hertz model is applicable to spherical tip and Sneddon model is applicable to conical tip. The formulae of Hertz-Sneddon model are following:
where υ is the Poisson ratio of cell (cells are often considered as incompressible materials and thus υ = 0.5). F is the loading force of AFM probe, δ is the indentation, E is the cellular Young's modulus, θ is the half-opening angle of the conical tip, and R is the radius of spherical tip. For applying Hertz-Sneddon model, the F-D curve is firstly converted into indentation curve according to the contact point in the F-D curve. The indentation δ is given by the difference between the distance change of AFM piezoelectric driver and the deflection of the cantilever [67] , [131] . Then Hertz-Sneddon model is used to fit the indentation curve. The inset in Fig. 3B is the comparison of Hertz-Sneddon fitting curve and experimental indentation curve, showing that the two curves match well. The fitting result gives the cellular Young's modulus E. Hertz-Sneddon model assumes that the sample is infinitely thick, but it works well when the indentation into the sample by the tip is less than 10% of the sample thickness [138] . In 2012, Gavara and Chadwick [139] have improved Hertz-Sneddon model to make it applicable for thin samples by introducing a bottom effect correction factor, significantly facilitating probing the mechanical properties of cellular lamellar structures such as pseudopodia. Cellular Young's modulus probed by AFM is influenced by experimental conditions, such as tip shape, probe loading rate, cellular positions being indented, environmental temperature and measurement medium [31] , and thus these conditions should be maintained identical during experiments. Cells are highly heterogeneous and the elastic properties of different subcellular structures are included in the diverse parts of the recorded force curves. At the small indentations, AFM tip probes the stiff cellular cortex which is composed of actin proteins [136] . At larger indentations, AFM tip probes the softer structures beneath the cellular cortex, such as cytoskeletons and cytoplasm [31] . When further increasing the loading force to indent the cells, the cell nuclei are probed by AFM [140] . Notably, measuring the elastic properties of cell nuclei inside intact cells requires the relative stiff cantilevers [141] .
3) Measurement of Cellular Viscoelasticity: Cellular relaxation time is obtained by analyzing the F-T curves obtained on cells. Generally, the F-T curve is fitted by Maxwell springdashpot model to obtain cellular relaxation time [142] . The formula of generalized Maxwell spring-dashpot model is:
where F is the loading force of the AFM probe, A 0 is the instantaneous (purely elastic) response, A i are the ith force amplitudes, τ i is the ith cellular relaxation time, η i is the ith cellular viscosity, and E i is the ith cellular Young's modulus. The cellular relaxation time (τ ) is the ratio of cellular viscosity (η) to cellular Young's modulus (E), and thus cellular relaxation time indicates the viscoelastic properties of cells. In practice, one-order Maxwell model often does not fit the F-T curve well, while two-order Maxwell model matches the F-T curve well [143] . The inset in Fig. 3C is the comparison of two-order Maxwell fitting curve and experimental relaxation curve, showing that the two curves are considerably consistent with each other. Fitting the relaxation curve with two-order Maxwell model gives two cellular relaxation times (τ 1 and τ 2 ). During AFM indentation process, AFM tip successively probes cell membrane and cytoskeleton. The first-order cellular relaxation time τ 1 (the fast relaxation time) originates from the rapid deformations of cell membrane, while the second-order cellular relaxation time τ 2 (the slow relaxation time) originates from the relatively slow reorganizations of cytoskeletons [144] . A notable point is that cellular relaxation times measured by AFM are dependent on the measurement parameters, such as surface dwell time and ramp rate [145] , and thus experimental conditions should be identical to make the obtained results comparable.
4) Single-Cell Mechanical Sensor:
AFM probe has been shown to be an ultra-sensitive mechanical sensor for probing the mechanical behaviors of single cells [146] [147] [148] [149] . The rounding force exerted by cells during mitosis can be measured and tracked by AFM cantilever as a nanomechanical sensor, as shown in Fig. 4A . A tipless cantilever is positioned over a cell and the vertical position of the probe is kept constant while the cell undergoes mitosis (Fig. 4AI ). When the cellular mitosis starts, the cell becomes round and contacts with the cantilever. The upward rounding force exerted by the cell causes the deflections of cantilever, which is used to quantitatively sense the rounding force of the cell [146] . By monitoring the deflection fluctuations of AFM cantilever, the dynamics of the cellular rounding force during mitosis is obtained (Fig. 4AII ), which has been used to investigate cell-drug interactions [147] . Besides rounding force [146] , [148] , the mass of single living cells can also be measured by AFM cantilever as a picobalance [149] , as shown in Fig. 4B . A low-power blue laser is focused at the base of the cantilever (Fig. 4BI ) to generate small cantilever oscillations (1-15Å). Attaching a cell to the cantilever of AFM changes the effective mass of AFM cantilever, which results in the changes of the natural resonance frequency of the cantilever. An infrared laser is reflected from the free end of the cantilever to detect the oscillation amplitude and frequency of the cantilever, which is used to extract the mass of the attached cell. Based on this method, the mass fluctuations during cellular pathological processes can be monitored. AFM single-cell probe is controlled to contact a virus-infected cell to transfer the virus to the cell attached to the AFM cantilever (Fig. 4BII) . The mass dynamics of the infected cell attached to the AFM cantilever is obtained successively and the results show the significantly different behaviors of mass between infected cells and healthy cells (Fig. 4BIII ), denoting the indicative role of cell mass for drug evaluations at single-cell level.
5) Single-Cell Force Spectroscopy:
Single-cell force spectroscopy has been used to measure the cellular adhesion forces. Cell probe is controlled to vertically perform approach-retract cycle on the substrate, as shown in Fig. 5A . Firstly, the cell probe gradually approaches the individual target cell grown on the substrate (Fig. 5AI ). After the cell probe contacts the target cell, the probe indents the target cell (Fig. 5AII ) until the preset force is achieved. Subsequently, the cell probe withdraws from the target cell (Fig. 5AIII ). When the pulling force is larger than the adhesion forces between cell probe and the target cell, the cell-cell bond ruptures and the cell probe returns to its original position (Fig. 5AIV) . By analyzing the force curves [150] recorded during the process, the cellular adhesion forces are obtained. A crucial factor which influences the single-cell force spectroscopy experiments is the preparation of cell probe. For cell probe, weak adsorption of cell to the cantilever may cause the sliding of cells during measurements, which results in the failure of the experiments. Commonly, cells are firmly attached to the cantilever via linker molecules (as shown in Fig. 5B ) [151] , which allows the reliable measurements of cellular adhesion forces.
For doing so, the cantilever is firstly coated by biotin-labeled bovine serum albumin (BSA). Then the cantilever is placed in the streptavidin solution, after which the cantilever is placed in the solution of biotin-labeled concanavalin A (ConA). The ConA-coated cantilever is then controlled to approach (Fig. 5BI ) the isolated cell on the substrate. After the cantilever contacts the cell with an adequate force (such as 1 nN) for a period of time (such as 2 s) (Fig. 5BII) , the cantilever retracts from the substrate (Fig. 5BIII ). Then the probe is kept in the medium for at least 10 min to allow the cell form firm contacts with the cantilever. Fig. 5BIV illustrates the linker molecules used in the preparation of cell probe. By single-cell force spectroscopy, studies have shown that the cellular adhesion forces (including cell-substrate adhesion [152] , [153] and cell-cell adhesion [154] ) are important indicators for cancer metastasis.
C. AFM Molecular Measurements
1) Single-Molecule Force Spectroscopy: AFM vertically performs approach-retract cycles on the cell surface with the functionalized tip carrying ligands to specifically probe the individual membrane receptors on the cell surface. As shown in Fig. 6A , the AFM functionalized tip, which is above the cell, firstly approaches the cell surface (I). After the tip contacts the cell, the AFM cantilever deforms. When the loading force achieves the preset value, AFM tip retracts from the cell surface. If molecular binding occurs during the contact between AFM tip and cell (II), the receptor-ligand complex is stretched by the AFM tip (III) during the retract process. When the pulling force exerted by the AFM cantilever is larger than the bond strength of receptor-ligand, the receptor-ligand molecular complex ruptures and then AFM tip returns back to its original position above the cell (IV). Fig. 6B shows the schematic diagram of force curve which corresponds to the approach-retract process of AFM tip described in Fig. 6A . The stretching of receptor-ligand molecular complex (III in Fig. 6A ) yields a clearly specific unbinding force peak in the retract portion of the curve (III in Fig. 6B ) and the magnitude of this peak is equal to the rupture force of the receptor-ligand pair. A notable point is that the density of ligands linked to the AFM tip is adjusted to best meet the expectation that only one ligand interacts with the receptors on the cell surface [155] , which ensures the detection of individual receptor-ligand unbinding events. Besides, since membrane proteins are often heterogeneously distributed on the cell surface, force curves are commonly recorded at different surface points of multiple cells to obtain statistical results and the probability for finding specific molecular unbinding events usually ranges from 10% to 30% [156] .
2) Experimental Procedure: The typical procedure of AFM single-molecule force recognition experiments is summarized in Fig. 6(C-F) . Before applying AFM force spectroscopy to probe the specific receptors on the cell surface, the expression of the receptors on the cell surface needs to be confirmed, which is often performed by fluorescence microscopy. Fig. 6C is the confocal microscopy imaging of a membrane hormone receptor on bladder cancer cells, clearly showing the existence of receptors on the cell surface [157] . As shown in Fig. 6D , under the guidance of optical microscopy, AFM functionalized tip is moved to the target cells to perform force spectroscopy experiments [158] . The inset in Fig. 6D shows the fluorescence image of the ligands of functionalized probe, which verifies that ligands are linked to the AFM tip. For the force curves obtained on the cell surface with ligand-conjugated tips, the curves possessing specific unbinding peaks indicate that specific molecular interactions are probed, as shown in Fig. 6E(I) . In order to demonstrate the specific molecular interactions, blocking experiments are required [89] . As shown in Fig. 6E(II) , after adding free ligands to block the receptors on the cell surface, the functionalized tip is used to obtain force curves on the cell surface. In this case, the obtained force curves do not have specific unbinding peaks (Fig. 6E(II) ), which proves the specific receptor-ligand interactions probed in Fig. 6E(I) . Besides, it is notable that the rupture force of receptor-ligand pair measured by AFM is dependent on the loading rate (retraction velocity multiplied by the spring constant of the cantilever) of AFM probe [159] . The dependence of the rupture force on the loading rate is theoretically described by the Bell-Evans model [155] , [160] , [161] :
where F is the rupture force, r is the loading rate, k of f (0) is offrate constant for dissociation in the absence of external force, x is the position of the energy barrier that should be overcome during the dissociation, k B is the Boltzmann's constant, T is the temperature. The formula (6) indicates the linear relationship between the measured rupture force and the logarithm of the loading rate. Hence, in practice, rupture forces are measured at different loading rates to investigate the dissociation dynamics of molecular interactions. In the plot of rupture force versus logarithm of loading rate, a single linear region indicates one energy barrier governing the dissociation process of separating the molecular complex, whereas two or more linear regions indicate the existence of multiple energy barriers needing to be overcome for separating the molecular complex [89] , [159] . When separating a virus from the membrane receptor of the cell surface, a single energy barrier needs to be overcome [101] , as shown in Fig. 6F . A virus establishes one or multiple connections with the cell surface, and all of the rupture forces increase linearly with the logarithm of the loading rates. For unbinding the molecular interactions between epidermal growth factor receptors and their ligands on the cell surface, two energy barriers need to be overcome [162] .
3) Tip Functionalization: AFM-based single-molecule force recognition studies require linking relevant ligands onto the AFM tips, which is often called tip functionalization. There are three main strategies for tip functionalization, including protein physisorption based on avidin-biotin, chemosorption of alkanethiols on gold-coated tips, and PEG covalent coupling of silanes on silicon tips [163] . The drawback of protein physisorption is that it requires biotinylation of ligands and the avidin-biotin system has a relatively low binding strength. Chemosorption of alkanethiols requires depositing a layer of gold on tip surface, which causes reduced spatial resolution. The covalent coupling method based on heterobifunctional PEG crosslinker can be directly performed on silicon tips. The binding strength of covalent bonds (1-2 nN) is about ten times stronger than typical receptor-ligand bonds [89] , which ensures that the receptor-ligand complex ruptures during the AFM single-molecule force spectroscopy experiments. Besides, the flexible PEG avoids mechanical compression of ligands on the AFM tip and allows clear discrimination between specific receptor-ligand unbinding events and nonspecific molecular unbinding events [93] . Hence, so far PEG covalent coupling has been the most widely used method for AFM tip functionalization [101] , [124] . Fig. 7A shows the schematic diagram of attaching ligands onto AFM tip via heterobifunctional PEG crosslinkers and Fig. 7B shows the typical procedure of tip functionalization. Notably, according to the different functional groups the ligands possess, PEG linkers with different reactive groups are used. For heterobifunctional PEG-based tip functionalization, amino-functionalization is firstly performed to coat the AFM tip with a layer of NH 2 . The NH 2 group is able to form covalent bonds with the NHS group at one terminus of the PEG linker, which attaches PEG linker to AFM tip. The last step is attaching ligands to the reactive groups at the other terminus of the PEG linker. For the ligands possessing NH 2 groups (such as antibodies), NHS-PEG-aldehyde or NHS-PEG-acetal is appropriate, which can attach unmodified ligands to the PEG linker [164] , [165] . For the ligands possessing free thiol (-SH) groups (such as proteins, cysteine peptides, thiolglucose), either NHS-PEG-maleimide or NHS-PEG-PDP works well [124] . For the ligands which are tagged with histidine groups (His-tag), NHS-PEG-nitriletriacetic acid (NTA) is used [94] , [166] . For more descriptions about AFM tip functionalization, readers are referred to the reviews [167] .
4) Single-Molecule Mechanical Unfolding: AFM is able to reveal the unfolding dynamics of single membrane proteins. Utilizing AFM single-molecule force spectroscopy to mechanically unfold the single membrane proteins is dependent on AFM high-resolution imaging of native membrane proteins 168], [169] , as shown in Fig. 8A . By attaching membrane patches containing reconstituted membrane proteins onto the solid and flat support (such as mica), AFM topography images of evenly distributed membrane proteins can be obtained in aqueous solution (Fig. 8AI) . After controlling AFM tip to unfold a membrane protein, AFM images of the samples are obtained again, clearly showing the small hole which corresponds to the disappearance of the unfolded protein (denoted by the circle in Fig. 8AII ). Fig. 8B shows the procedure of unfolding single membrane proteins by AFM [170] . Based on AFM imaging, the AFM tip is moved and pushed onto a single membrane protein (Fig. 8BI) , applying forces of ∼0.5-1 nN for ∼1 s, during which the protein peptide adsorbs to the AFM tip with a probability of ∼5-10% [171] . Then the AFM probe is pulled away from the membrane, which mechanically unfolds the membrane protein.
Force curves are recorded during the approach-retract process of AFM tip. The recorded force curve with membrane protein unfolding events often shows the sawtooth-like pattern of force peaks (Fig. 8BII) , each of which corresponds to the unfolding of a segment of membrane protein [172] . The force curve is commonly fitted by the worm-like chain (WLC) model [168] [169] [170] [171] [172] [173] to analyze the unfolding pathway of the protein:
where F(x) is the force, L 0 is the contour length of the peptide, l p is the persistence length of the peptide (usually 0.4 nm for protein [173] ), x is the extension of peptide, k B is the Boltzmann's constant, and T is the temperature. Each sawtooth-like peak is fitted by the WLC model. Based on WLC fitting, the number of amino acids is calculated, and then the unfolding pathway of the protein is obtained.
IV. AFM CELLULAR TOPOGRAPHY IMAGING
A. Motivation and Overview
Imaging the fine structures of cancerous cells is the basic applications of AFM in physical oncology. Cell membrane has been shown to be able to differentiate cancerous cells from their healthy counterparts. Cell membrane is composed of a few nanometers thick lipid bilayer with embedded biomolecules (e.g., proteins, glycoproteins) [174] . When a healthy cell transforms into a cancerous cell, the structure of cell membrane changes significantly. The lipid composition in the cell membrane of cancerous cells is significantly different from that of normal cells, for example, cancerous cells often have different amounts of cholesterol compared with normal cells [175] . Cells containing low amount of cholesterol are compliant and can enter blood vessels easier (this is important for cancer metastasis), while cells containing high amount of cholesterol are rigid and are less permeable [176] . On the cell membrane, glycoproteins, proteoglycans and glycosaminoglycans collectively organize into glycocalyx [6] , [177] . Studies have shown that the glycocalyx on the cell membrane of cancerous cells is quite different from that of normal cells [178] . As shown in Fig. 9 , normal cells have short glycocalyx, which allows a uniform distribution of integrins in the membrane. By contrast, cancerous cells have long glycocalyx, which results in the clustering of integrins and the membrane bending. These physical effects influence the functions of cancerous cells by altering cell signaling, which promotes cell growth and survival for cancer metastasis. The membrane proteins of cancerous cells are also different from that of healthy cells. Cancerous cells have less E-cadherin molecules than normal cells [4] , which facilitates cancerous cells detach from the primary tumors for metastasis. Sometimes cancerous cells express specific antigens recognized by T lymphocytes, which has been used for cancer immunotherapy [179] . Besides, the expression levels of specific membrane proteins also alter when a normal cell becomes cancerous, such as breast cancer cells [180] . These huge alterations in cell membrane compositions and organizations cause the unique cellular surface morphology of cancerous cells, and thus utilizing AFM to image the ultra-microstructures of cell surface is useful for understanding cancerous cells.
AFM cellular topography imaging provides novel insights into the physiological activities of cell surface. An important point in AFM cellular topography imaging is the immobilization methods by which cells are attached onto the substrate. The immobilization methods are variable for different types of cells [181] . Microbial cells can be mechanically immobilized with the use of porous polymer filtration membrane [182] . A harvested cell suspension is gently sucked through in the filtration membrane with a pore size that is similar to the size of the cells. Generally, 3-μm pore size is fine for spores, while 0.8-and 5-μm pores should be used for bacteria and yeast respectively [183] . Microbes can also be immobilized by polydimethylsiloxane (PDMS)-fabricated microwell mechanical trapping [184] or poly-L-lysine electrostatic adsorption [185] . Both porous polymer filtration membrane and PDMS microwell are generally not suited for rod-shaped microbes like Gram-negative bacteria [183] , while poly-L-lysine electrostatic adsorption is suited for virtually all types of microbes. However, coating substrate with poly-L-lysine modifies the interface of samples, which may influence cell behaviors. Based on AFM imaging, various fine structures on the surface of microbes have been revealed, such as structural dynamics of single germinating bacterial spores [186] , molecular dynamics on single living bacterial surface by high-speed AFM [187] , the nanoscale organization of peptidoglycan in bacterial cells [188] , and the invasion dynamics of fungal pathogens into macrophages [189] . For adherent animal cells, they are able to naturally attach and spread on the substrate, and thus these cells can be directly imaged by AFM without extra immobilization methods. By peak force tapping AFM imaging, the individual microvilli on living Madin-Darby canine kidney (MDCK) cells are clearly revealed [190] . With high-speed AFM, the pits formation during the dynamics of cellular endocytosis [191] , the activities of single membrane proteins on eukaryotic cells [192] , and cortical actin dynamics in living cells [193] have been successively recorded. The cell membranes of animal cells are soft and are easy to be deformed by AFM tip, which limiting the spatial resolution of imaging these cell membranes. By preparing cell membrane patches and attaching them onto the substrate, the activities on the cell membrane can be acquired by AFM imaging with higher spatial resolution. By exerting slow or fast stream of hypotonic buffer solution on erythrocytes which are attached to chemically modified mica, the outer membrane and inner membrane of erythrocytes can be prepared respectively [127] . Based on this method, the structural dynamics of membrane lipids in response to drugs were clearly revealed [194] , providing novel insights into the structure and function of cell membranes [195] .
B. Applications in Lymphomas 1) Morphological Dynamics During Drug-Cell Interactions:
AFM imaging significantly reveals the cellular topography changes taking place during the rituximab-induced three killing mechanisms of B lymphoma cells, as shown in Fig. 10 . During PCD, the binding of rituximab to CD20 on lymphoma cells results in the apoptosis of cells (Fig. 10AI) . Lymphoma cells are suspended animal cells. They cannot naturally attach to the substrate and have soft surface. In order to image the topography of living lymphoma cells, we have developed an immobilization method which combines micropillar mechanical trapping and poly-L-lysine elestrostatic adsorption [74] . The silicon micropillar array chips were fabricated by photolithography and the chips were coated by a layer of poly-L-lysine. Poly-L-lysine vertically attaches cells onto the substrate while pillars horizontally trap cells, achieving three-dimensional immobilization of lymphoma cells. As shown in Fig. 10AII , the immobilization methods allows imaging individual living lymphoma cells captured by four pillars. AFM images of local areas on the cell surface showed the rough cell surface (Fig. 10AIII) . Based on this immobilization method, the cellular morphological changes during rituximab's PCD mechanism were observed [75] . AFM imaging of living lymphoma cells after the treatment of rituximab showed that cell surface exhibited significantly changes, such as corrugated morphology (Fig. 10AIV ) and turbercle structures (denoted by the arrows in Fig. 10AV ) appeared on the cell surface. During rituximab's CDC mechanism, MACs form on the cell surface to lyse cells (Fig. 10BI) . By incubating B lymphoma cells with rituximab and human serum for 2 h at 37°C(5%CO 2 ), the rituximab-induced CDC effects on the cells were triggered, which was confirmed by fluorescence imaging. AFM imaging of the lymphoma cells clearly revealed the porous structures on the cell surface [196] , as denoted by the arrows in Fig. 10B(III, IV) . Pores with variable sizes were observed. The appearance of these pores were due to the MACs in rituximab-mediated CDC effects. Besides, the fusion of two or more pores were revealed (denoted by the arrows in Fig. 10BV ), indicating that the pores formed on the cell surface gradually became larger. During rituximab's CDCC mechanism, macrophages engulf B lymphoma cells (Fig. 10CI) . By coating B lymphoma cells with rituximab and then incubating them with macrophages, the phagocytosis phenomenon was observed [197] . Lymphoma cells were clearly discriminated from macrophages from AFM images according to cell shape, as shown in Fig. 10C(II, IV) . Lymphoma cells are suspended cells and have circular shape, while macrophages are adherent cells and spread on the substrate. AFM imaging revealed the dynamic process of phagocytosis. Fig. 10CIII shows the initial contact between a macrophage and a lymphoma cell, and Fig. 10CV shows that the macrophage began engulfing the lymphoma cell. The results of Fig. 10 provide direct visual evidence of rituximab's mechanisms in vitro from the point of cell surface ultra-microstructure dynamics, improving our understanding of rituximab's therapeutic effects on lymphoma cells.
2) Cell Surface Roughness is a Quantitative Indicator: AFM cell surface imaging and roughness analysis provides a novel way for quantitatively characterizing the synergistic reactions between targeted drugs and chemotherapy drugs. In practice, rituximab is often combined with chemotherapy drugs for treating B-cell lymphomas [198] [199] [200] [201] . In this case, it is difficult to exactly evaluate the contribution of rituximab to the clinical therapeutic outcomes [52] , [54] . Hence, investigating the effects of rituximab on chemotherapy drugs on lymphoma cells is useful for understanding the clinical treatments of B-cell lymphomas. With the use of AFM, the cellular morphological changes after the treatments of various combined drugs were significantly revealed [202] , as shown in Fig. 11 . Two commonly used chemotherapy drugs in the rituximab-based immunochemotherapy treatment of lymphomas were examined, including cisplatin [203] and cytarabine [204] . Cisplatin is able to cross-link DNAs in the cell, which causes DNA damage and eventually induces the apoptosis of cells. Cytarabine is able to disturb the synthesis of DNA, which impedes the proliferation of cells. Lymphoma cells were treated with chemotherapy drugs alone or treated with combined drugs. Fig. 11A are the AFM images of lymphoma cells from control group (without drug treatments), and Fig. 11B are the AFM images of lymphoma cells after drug treatments, significantly showing that cell surface becomes rougher after drug treatments. Drug stimulation resulted in the morphological changes of cell surface, such as appearance of pores (denoted by the arrows in Fig. 11BII , III) and bulges (Fig. 11BIV-VI) . Quantitative information about cell surface morphology is obtained by calculating the roughness of cells from AFM height images:
where R q is the root-mean-square roughness, N is the number of pixels within the selected region of the AFM image, Z i is the height value of the pixel in the AFM image. Fig. 11C shows the statistical results of cell surface roughness after the treatments of drugs with different stimulation times. The results significantly showed that chemotherapy drugs caused the rougher cell surface and the combined use of rituximab and chemotherapy drugs further caused the rougher cell surface, indicating the enhancing effects of rituximab to chemotherapy drugs on depleting lymphoma cells from the perspective of cellular surface roughness. The results of Fig. 11 demonstrate the potential of AFM topography imaging in quantitatively investigating actions of combined drugs at the single-cell level, which will be useful for evaluating drug contribution in combination treatments.
V. AFM CELLULAR MECHANICAL MEASUREMENTS
A. Motivation and Overview
Cell mechanics plays an important role in regulating cancer development and metastasis. In 2007, Suresh [205] summarized the relationships between cell structure, cell mechanics and cell functions involved in cancer, as shown in Fig. 12A . The action of carcinogens cause the changes of cellular geometries and structures. For example, when a normal cell converts into a cancerous cell, the size of cell nuclei often increased and the nuclear contour becomes irregular [206] . The shape of cancerous cells is different from that of normal cells. For cancer metastasis, cancer cells detach from the primary tumor, which causes the changes of cell shape by the mechanism of epithelial-mesenchymal transition (EMT) [207] . EMT results in the spindle-shaped cellular morphology, which facilitates cell migration [208] . Cancerous cells have different sizes compared with normal cells. The diameter of circulating tumor cells (CTCs) is often significantly larger than that of blood cells in the blood vessel, which promotes CTCs to be trapped at the capillaries for invasion [209] . There are also significant alterations in cytoskeletons between cancerous cells and normal cells. Normal cells have well-aligned actin filamentous structures while the actin in cancerous cells appears as a randomly organized network [210] , as shown in Fig. 12B . Cytoskeletons are important determinants for cellular mechanical properties [211] . The reorganizations of cytoskeletons affect the mechanical properties of cells such as deformability for achieving physiological functions. Studies based on microfluidics have shown that the entry time of cancerous cells into the microchannel is significantly smaller than that of normal cells, indicating that cancerous cells are more deformable than normal cells [212] , which facilitates cancerous cells to pass through the extracellular matrix for metastasis. There are also differences between cancerous cells and normal cells in cell surface components (as shown in Fig. 9 ), which directly alter the adhesion ability of cells [4] . The alterations of cellular mechanical properties result in the changes of cell functions, such as locomotion and motility, which eventually affect the disease states. Consequently, detecting cell mechanics is of important significance for understanding the underlying mechanisms guiding the behaviors of cancers.
AFM has been widely used to investigate the cellular mechanical properties involved in cancer progression and metastasis. In 1999, Lekka et al [213] firstly used AFM to measure the Young's modulus of cancer cells, showing that the Young's modulus of normal bladder cells is about ten times larger than that of cancerous bladder cells. In 2008, Li et al [210] used AFM to analyze the mechanical differences between cancerous breast cells and normal breast cells, showing that non-malignant breast cells (MCF-10A) have an apparent Young's modulus which is significantly larger (1.4-1.8 times) than that of their malignant counterparts (MCF-7). These studies [210] , [213] were performed on cell lines grown in vitro which are quite different from the real cancerous cells in vivo. In 2007, Cross et al [11] directly measured the Young's modulus of cancerous cells prepared from the body cavity fluid samples of cancer patients. Cancer cells were recognized by their specific shape, which was confirmed by immunofluorescence labeling. AFM measurements showed that the metastatic cancerous cells (with Young's modulus about 0.5 kPa) is significantly softer than benign cells (with Young's modulus about 2 kPa). In 2012, Plodinec et al [13] directly probed the primary breast tissues prepared from breast cancer patients, showing the significant differences in stiffness profiles between normal tissues and malignant tissues. Further evidence obtained from mice showed that low stiffness of cancerous cells promoted tumor migration and metastasis. In 2016, with the use of multiparametric AFM, Calzado-Martin et al [214] simultaneously obtained the morphology images and stiffness images of three breast cancer cell lines with different degrees of malignancy: MCF-10A (healthy cell), MCF-7 (noninvasive cancerous cell) and MDA-MB-231 (invasive cancerous cell). Cytoskeletons were also imaged by immunofluorescence labeling. The combination results clearly showed the well-aligned filamentous actins of healthy cells, which resulted in apparent Young's modulus values up to 1 order of magnitude larger than those in regions where these structures were not observed. On the contrast, the organized actin fibers were barely observed in cancerous cells. The results directly indicate that actin fibers provide a dominant contribution to stiffness of cells, showing the ability of AFM in simultaneously revealing the relationship between cell structures and cell mechanics. In 2017, by using highspeed AFM, Rigato et al [215] performed active high-frequency microrheology on living cells to observe cellular viscoelastic behaviors at short timescales. AFM tip oscillating at different frequencies (1 Hz∼100 kHz) was used to probe the viscoelasticity of cells. The results revealed that benign and malignant cancerous cells remarkably exhibited different scaling laws at high frequencies, providing a unique mechanical fingerprint to discriminate cancerous cells from their normal counterparts.
B. Applications in Lymphomas 1) Cellular Mechanical Dynamics During Drug Actions:
AFM single-cell indentation reveals the mechanical dynamics in the physiological activities of lymphoma cells, as shown in Fig. 13 . By gluing microspheres onto AFM cantilever via epoxy adhesive, the spherical tip was prepared. Using spherical tip, the Young's modulus of three types of lymphoma cells with different degrees of malignancies was measured [216] , including Raji cell (Burkitt's lymphoma cell line), K562 cell (chronic myelogenous leukemia cell line), and Hut cell (cutaneous T lymphoma cell line), as shown in Fig. 13A . For comparison, red blood cells (RBCs) from healthy volunteers were also measured. For the four types of cells, RBCs do not have cell nucleus and had smallest Young's modulus. For the three types of lymphoma cells, the results showed that aggressive cancerous cells (Raji) were significantly softer than indolent cancerous cells (K562 and Hut), indicating that softening plays an important role in cancer progression. The actions of rituximab on lymphoma cells result in significantly cellular mechanical changes. Fig. 13B shows the Young's modulus changes of lymphoma cells during rituximab's CDC and PCD effects [75, 196] . For lymphoma Raji cells without rituximab treatment (Fig. 13BI) , there was significant hysteresis gap between approach curve and retract curve. For Raji cells with CDC effects, cells exhibited red fluorescence after propidium iodide (PI) staining and the hysteresis gap was not obvious (Fig. 13BII) . Besides, there was a characteristic peak in the approach curve (denoted by the arrow in Fig. 13BII ), which indicated that AFM tip penetrated cell membrane [217] . During rituximab's CDC effects, micro pores formed on the cell surface (as shown in Fig. 10B ). When AFM tip probed these pores during indentation, AFM tip penetrated cell membrane, which resulted in the force peak in the approach curve. Statistical results showed that the direct stimulation of rituximab via PCD effects on lymphoma cells caused the decrease of cellular Young's modulus, while the activation of rituximab-mediated CDC caused the significant increase of cellular Young's modulus (Fig. 13BIII) , revealing that cells firstly softened but finally stiffened during rituximab's killing effects. During rituximab's ADCC effects, macrophages engulf the rituximab-bound lymphoma cells. AFM indenting was applied to analyze the mechanical changes of macrophages after phagocytosis [197] , as shown in Fig. 13C . Statistical results clearly showed that macrophage stiffened when it captured and then engulfed lymphoma cells. In antibody-dependent macrophage phagocytosis, actin cytoskeletons of macrophage rapidly polymerized to assist in engulfing cancer cells [218] . The polymerized actin cytoskeletons then resulted in the stiffening of macrophages during phagocytosis. Cell mechanics also exhibits significant changes during the combination use of chemotherapy drugs and rituximab [202] , as shown in Fig. 13D . Two chemotherapy drugs were used, including cisplatin and cytarabine. Lymphoma Raji cells were treated by chemotherapy drug alone or treated by chemotherapy drug and rituximab. When Raji cells were treated by combination drugs, the representative force curves recorded on cells had significantly larger slope than the force curves obtained on cells which were only treated by chemotherapy drugs (Fig. 13DI, II) , indicating the increase of cellular Young's modulus after the use of combination drugs. When live cells became dead, cellular Young's modulus increased [196] , [219] . Statistical results clearly showed the stiffening of cells after treatments combining rituximab and chemotherapy drugs, indicating the enhancing effects of rituximab to chemotherapy drugs on killing lymphoma cells, providing a novel way for quantitatively evaluating drug actions.
2) Mechanical Detection of Primary Cells: AFM single-cell indentation assay has been shown to be able to directly probe the mechanical properties of primary lymphocytes, as shown in Fig. 14 . Current studies of AFM-based cellular mechanical assays are commonly carried out on cell lines cultured in the artificially controlled environments in vitro, which are quite different from the cells grown in the native environments in vivo [220] . The results obtained on cell lines do not always accurately replicate the primary cells [221] . In order to detect the mechanical properties of primary B lymphocytes by AFM, the prerequisite is isolating lymphocytes from biopsy samples [130] , [143] , [145] , as shown in Fig. 14A . By density gradient centrifugation and CD19 magnetic beads labeling, the B lymphocytes from the peripheral blood of healthy volunteers were obtained. After isolating primary lymphocytes, the next issue is how to verify that the obtained cells were B lymphocytes, which can be performed by biochemical fluorescence staining experiments, as shown in Fig. 14B . The biological activities of the obtained cells were confirmed by CFSE and PI staining, while the species of the cells was confirmed by CD20 labeling which is a specific cell surface marker exclusively expressed on B lymphocytes. By AFM imaging, the topography of the primary healthy B cells was obtained and cellular geometries were measured, showing that the sizes of primary B cells were significantly smaller than that of Raji cell line (cancerous B cells) (Fig. 14C) . By controlling AFM probe to indent the isolated primary B cells under the guidance of optical microscopy ( Fig. 14DI) , F-D curves (Fig. 14DII ) and F-T curves (Fig. 14DIII ) were recorded to analyze the elastic and viscoelastic properties of cells respectively. There were no adhesion forces on the approach curve of F-D curves, while two-order Maxwell model fitted the F-T curves well. Fig. 14E shows the statistical results of Young's modulus and relaxation times of primary healthy B cells and Raji cancerous B cells, showing that the Young's modulus of cancerous cells was significantly smaller than that of healthy cells and the relaxation time τ 2 of cancerous cells was significantly larger than that of healthy cells. The results indicate the different mechanical behaviors between primary cells and cell lines. Further the mechanical properties of primary B cells prepared from peripheral blood and bone marrow of clinical lymphoma patients were measured and compared [145] , showing that the mechanical responses of primary B cells from peripheral blood were also different from the primary B cells from bone marrow. The AFM mechanical measurements on primary cells demonstrate the capabilities of AFM in detecting the mechanics of primary cells and provide novel insights into understanding cell mechanics.
VI. AFM MOLECULAR FORCE RECOGNITION
A. Motivation and Overview
Molecular mechanics plays a crucial role in the physiological activities of molecules, which affects cellular functions and eventually influences the healthy states of living organisms. The behaviors of cellular membrane proteins (e.g., receptor, ion channel, transporter, enzyme) are related to diverse cellular processes, including cell adhesion, tissue development, cellular communication, inflammation, tumor metastasis, microbial infection and so on [222] . These membrane proteins dynamically interact with other biomolecules (e.g., lipid, carbohydrate) to form supramolecular assemblies (e.g., lipid rafts [223] ) to perform particular biological functions [224] . Membrane proteins acquire their unique biological functions through folding of their peptides into a unique and stable three-dimensional structure [163] . The driving forces of the folding processes are generated by diverse molecular interactions such as hydrophobic, hydrophilic, electrostatic, van der Waals and hydrogen bonding [91] . The folding processes result in the unique mechanical properties of the membrane proteins [225] , which can be investigated by directly applying mechanical force on the folded proteins to unzip the proteins [226] . On the contrary, protein misfolding, which is an important cause of diverse neurodegenerative diseases, yields abnormal mechanical properties of the proteins [227] , [228] . Membrane proteins are also important targets for drugs, so far approximately 50-60% of drug targets are located at the cell surface [229] , [230] . The mechanical properties of targets (e.g., binding affinity to drugs, target distribution on the cell surface and drug-target residence time [231] ) are important determinants for the therapeutic outcomes. The alterations of the mechanical properties of the targets on the cell surface are often accompanied with the changes of therapeutic efficacies of drugs, for example, studies have shown that decreased drug-target binding affinity is related to drug resistance [232] . Hence, investigating the mechanical behaviors of membrane molecules is of considerable significance for understanding the underlying mechanisms guiding molecular interactions, disease pathology, or drug-target interactions. However, traditional biochemical assays (e.g., Western blotting [233] , fluorescence staining [234] ) require lysing or labeling cells, which provides limited information about the native activities of membrane biomolecules on the cell surface.
AFM achieves remarkable success in detecting the biophysical and biomechanical properties of individual membrane molecules on the cell surface by force spectroscopy with biosensitive tips. Due to the soft, corrugated and dynamic characteristics of the cell membrane, so far the spatial resolution of AFM imaging on living mammalian cells is about 50 nm [235] , which is insufficient to discern individual molecules on the cell sur- face. Besides, there are many different types of biomolecules on the cell surface, and they are often morphologically indistinguishable from each other [236] . In order to make AFM tip specific to target receptors on the cell surface, the corresponding cognate ligands need to be linked to the surface of AFM tip. In 1994, Florin et al [237] firstly demonstrated that AFM was able to specifically probe individual molecular interactions with the use of functionalized tip, but notably a limitation of the functionalized method used in this study was that multiple molecular binding events were often observed. In 1996, Hinterdorfer et al [155] developed a 8-nm-long flexible polyethylene glycol (PEG) linker which was used to attach antibody molecules onto the surface of AFM tip. With the antibody-conjugated tip to obtain force curves on the substrate, single antigen molecules on the substrate were specifically sensed and the individual antibodyantigen binding forces (244±22 pN) were directly measured. Through the PEG-based tip functionalization method, the binding affinities of diverse types of membrane biomolecules on the living cells have been investigated, such as transporters on Chinese hamster ovary (CHO) cells [238] , sensors on yeasts [239] , fibrinogen receptors on erythrocytes [240] , epidermal growth factor receptors on HEK 293 cells [241] , and human hormone receptors on bladder cancer cells [157] , providing novel insights into the mechanics of individual molecular activities on cell surface. With AFM force spectroscopy techniques, the interactions between single virus and receptors on cell surface have also been investigated, including rabies viruses [101] , rhinoviruses [242] , filamentous bacteriophages [243] , and influenza viruses [244] . Besides, a recent study by Guedes [245] has shown that the molecular binding forces of primary cells revealed by AFM are able to indicate the risk of cardiovascular diseases in patients, showing the translational medicine significance of AFM molecular force recognition spectroscopy.
B. Applications in Lymphomas
In recent years, researchers have utilized AFM singlemolecule force recognition spectroscopy techniques to investigate the molecular behaviors involved in lymphoma targeted treatments (as shown in Fig. 15 ) [246] [247] [248] [249] [250] , demonstrating the capabilities of AFM in probing individual membrane proteins on primary cancerous cells prepared from clinical lymphoma patients and providing novel insights into nanoscale drug-target interactions on primary lymphoma cells.
1) Primary Lymphoma Cell Recognition:
In order to probe the CD20-rituximab interactions directly on primary lymphoma cells, the prerequisite is isolating primary lymphoma cells from the biopsy samples. The bone marrow obtained from advanced B-cell lymphoma patients [251] contains several different types of cells, including cancerous B cells, healthy B cells, and other healthy cells (Fig. 15A) . In the past decade, studies have shown that receptor tyrosine kinase-like orphan receptor 1 (ROR1) is selectively expressed on cancerous B cells (e.g., B-cell lymphomas and chronic lymphoid leukemia), whereas normal B cells and other normal cells do not express ROR1 [252] [253] [254] . Hence, ROR1 is an adequate biomarker for recognizing cancerous B cells from the bone marrow of lymphoma patients. Before utilizing ROR1 fluorescence to recognize cancerous B cells of biopsy samples prepared from lymphoma patients, ROR1-based recognition was examined on lymphoma Raji cells (a cancerous B cell line derived from a Burkitt's lymphoma patient) [246] . Raji cells were firstly incubated with anti-ROR1 antibodies and then were incubated with fluorescein-conjugated secondary antibodies, clearly indicating that Raji cells express ROR1 (as shown in the inset of Fig. 15A ). The goal is detecting CD20s on the ROR1-labeled cells, and thus a notable point is whether ROR1 labeling will influence the expression and detection of CD20s on the cell surface. Subsequently, anti-CD20 fluorescence labeling (for examining CD20 expression) and AFM force spectroscopy (for examining CD20 detection) experiments were performed on the ROR1-labelled Raji cells, showing that ROR1 labeling did not influence the detection of CD20s on the cell surface. Then ROR1 labeling was performed on the bone marrow cells prepared from advanced B-cell lymphoma patients [247] , [248] . Fig. 15B shows the optical image of bone marrow and Fig. 15C shows the results of ROR1 labeling on the bone marrow cells. Many cells are discernible from the bright field image (Fig. 15CI) , among which some cells exhibit fluorescence from the corresponding ROR1 fluorescence images (Fig. 15CII) . Since only cancerous B cells express ROR1, the fluorescence indicates cancerous B cells. For control, ROR1 labeling was performed on the peripheral blood cells of healthy volunteers and no fluorescent cells were observed, indicating that normal cells did not express ROR1. Then the geometric features of cancerous B cells and healthy cells were characterized by AFM imaging (Fig. 15D) . Under the guidance of ROR1 fluorescence, AFM probe was moved to cancerous cells (Fig. 15DI ) to obtain topography images. For control, healthy cells which did not exhibit fluorescence (Fig. 15DII) were also imaged by AFM. The diameters of cells were calculated based on AFM topography images (Fig. 15DIII) , showing that cancerous cells were significantly larger than healthy cells.
2) Molecular Mechanics of Primary Lymphoma Cells:
The CD20-rituximab interactions on primary lymphoma cells are detected by AFM single-molecule force recognition spectroscopy based on ROR1 fluorescence recognition. With the assistance of ROR1 fluorescence, AFM tips functionalized with rituximabs were moved to cancerous B cells to perform force spectroscopy [246] [247] [248] . Fig. 15E shows representative force curves obtained on cancerous B cells and healthy cells with rituximabconjugated tips respectively. Since erythrocytes have special cell shape (oval biconcave disk) which can be easily recognized from optical images and AFM images, force curves were also obtained on erythrocytes for control studies. For cancerous cells, specific unbinding peaks are clearly observed in the force curves (Fig. 15EI) , whereas only unspecific unbinding peaks are observed for healthy cells (Fig. 15EII) . Force curves were recorded at different surface areas on multiple cells to acquire statistical results, as shown in Fig. 15F . For cancerous cells, the probability of finding specific molecular unbinding events is about 17% and the rupture force of CD20-rituximab specific interactions is about 54 pN (Fig. 15FI) . For healthy cells, the probability of finding unspecific molecular unbinding events is about 3% and the rupture force of unspecific molecular interactions is about 21 pN (Fig. 15FII) , indicating that the unspecific molecular rupture force is significantly smaller than that of specific molecular rupture force. Arrays of force curves (16 × 16) were obtained at local areas (500 × 500 nm 2 ) on cell surface to map the spatial distributions of CD20s on the cell surface. A specific molecular rupture force was calculated from each force curve. After converting the force values into the range 0-255, the gray map of forces was constructed (Fig. 15G) . In the force maps, the black pixels indicate no molecular unbinding events and the gray pixels indicate molecular unbinding events, showing that CD20s distribute heterogeneously on the cell surface (Fig. 15GI ). For contrast, there are few gray pixels on healthy cells, which indicate unspecific molecular binding events. In order to examine whether the gray pixels correspond to the CD20-rituximab unbinding events, blocking experiments were carried out. After adding free rituximabs to block the CD20s of cancerous B cells, arrays of force curves were obtained on cancerous B cells again (Fig. 15GII) and the results clearly showed the remarkable decrease of gray pixels, demonstrating the specific CD20-rituximab interactions.
AFM single-molecule force recognition provides novel insights into the molecular activities on primary cells involved in lymphoma treatments. In order to examine the clinical significance of CD20 mechanics, AFM force spectroscopy studies were performed on cancerous B cells for three B-cell lymphoma patients who received rituximab therapies. Before rituximab therapies, the bone marrow of patients was obtained and the CD20-rituximab interactions on the cancerous B cells were detected by AFM. The comparison of AFM detection and clinical therapies showed that larger distribution density of CD20s on the cell surface was accompanied with better rituximab therapeutic outcomes [248] , showing the potential indicative significance of AFM-based molecular assays. A notable point is that diverse types of molecular interactions take place during rituximab's killing effects to lymphoma cells. For example, as shown in Fig.-1 , besides CD20-rituximab binding, the interactions between Fc receptors (FcR) on effector cells and rituximab also contribute to the rituximab's ADCC mechanisms. Based on NKp46 fluorescence recognition (NKp46 is exclusively expressed on NK cells but not on other cells), NK cells from the biopsy samples prepared from clinical B-cell lymphoma patients were identified and then the FcR-rituximab interactions on NK cells were detected by AFM [249] . Further, the comparison of AFM detection and clinical rituximab efficacies showed that high binding affinity and distribution of FcRs on NK cells were accompanied with better rituximab therapeutic outcomes, indicating the important role of FcR mechanics in rituximab's actions. Current AFM single-molecule studies are commonly carried out on cell lines grown in vitro [157] , [238] , [241] , which cannot fully reflect the clinical situations. Directly probing the mechanics of individual membrane proteins on primary cells prepared from clinical cancer patients is closer to the real clinical environments, which thus provides novel insights into molecular behaviors involved in cellular functions and drug actions.
VII. AFM DETECTION OF TISSUE PHYSICS
Cell-microenvironment interactions play an important role in promoting the invasion and metastasis of tumor cells. As shown in Fig. 16A , cancer metastasis contains several typical steps of physical interactions between tumor cells and their microenvironments, including breaching basement membrane, migrating through extracellular matrix, squeezing into blood or lymphatic vessels, and forming colonies at distant sites [255] . All of these steps involve physico-chemical processes, such as adhesion and deformation, which are dependent on the local microenvironment [4] . For example, an important factor which influences the behaviors of tumors is the cancer-associated fibroblasts (CAFs) [256] . Compared with normal tissue fibroblasts, CAFs have increased proliferation, enhanced extracellular matrix production and unique cytokine secretion [257] , which promotes tumorigenesis. During the metastasis of tumor cells, the primary tumor sends signals in advance via extracellular vesicles called exosomes to the distant sites to make the microenvironment of the distant sites suitable for the growth of the coming tumor cells [258] . Successful metastasis of tumors is not determined solely by genetic alterations in tumor cells, but also by the adequate mutations in the tumor microenvironment [257] . In fact, the interactions between tumor cells and their microenvironments often result in the additional phenotypic mutations of tumor cells [259] , which further increases the heterogeneity of tumors. Due to the important role of tumor microenvironment in tumorigenesis and metastasis, targeting tumor microenvironment (e.g., stromal cells [260] , adhesion molecule [261] ) has achieved significant progress in the therapy of cancers. Hence, investigating the behaviors of tumor microenvironment is of fundamental significance for uncovering the underlying mechanisms guiding tumor development and progression.
AFM has been shown to be able to probe the physical properties of tissue and extracellular matrix. In 2011, Lopez et al [262] used AFM to investigate the stiffness of mammary tissues during mammary tumorigenesis. The MMTV-PyMT mouse model was used. The presence of mammary gland lesions were detected by physical palpation. Tumors were excised and then cut into 20-μm sections for AFM detection. The results showed that mammary tumor was significantly stiffer than mammary ducts. Further the mechanical properties of tumor epithelium, tumor-associated vasculature and extracellular matrix were measured respectively, showing that they all contributed to the stiffening of tumors but exhibited different mechanical alterations during tumorigenesis. In 2015, the same group [263] applied AFM to investigate the mechanical dynamics taking place in the invasion and aggression of human breast cancers. Human breast tissue samples were collected from patients. The results showed that human breast cancer transformation was accompanied by an increase in collagen deposition and a progressive linearization and thickening of interstitial collagen, which resulted in the stiffening of tumor stroma. Besides, it was found that the stromal stiffness was positively correlated with the number of infiltrating tumor-activated macrophages, improving our understanding of breast cancers from the perspective of biomechanics. In other studies, researchers used AFM to investigate the correlation between the mechanics and structures of extracellular matrix prepared from biopsy tissues [264] [265] [266] , as shown in Fig. 16B . Extracellular matrix was obtained by removing cells via a decellularization process (Fig. 16BI ) which preserved the composition, structure and mechanical properties of the extracellular matrix. The decellularized matrices were cut into slices with 12 μm thick. The slices were immobilized onto glass slides and measured by AFM in buffered saline (Fig. 16BII) . The slices were stained with fluorescence for structural observations, showing that collagen fibers and elastin were rich in the matrices. Simultaneously, AFM mechanical measurements visualized the stiffness distributions of the matrices, showing that elastin-rich areas were significantly stiffer than collagen-rich areas (Fig. 16BIII) , which is useful for evaluating the physics of tissue matrices.
AFM characterization provides novel insights into the physical behaviors of tumor basement membrane during tumor invasion. Basement membranes are thin, dense sheets of specialized, self-assembled extracellular matrix that surround most animal tissues [267] . The core structural components of basement membranes are laminins, collagen IV, nidogens, perlecans and agrins [268] . Rather than just a structural feature of tissues, basement membrane has been found to be involved in the regulation of tumorigenesis and progression [268] . Hence, investigating the behaviors of basement membranes is of significance for understanding tumors. In 2017, Glentis et al [270] used AFM to investigate the dynamic reorganizations of basement membranes during the process of cancer cell invasion induced by cancerassociated fibroblasts, as shown in Fig. 16C . Staining human colon carcinoma samples with fluorescent dyes clearly showed a several layers thick capsule of muscle cells around the tumor, co-localizing with intact and continuous basement membranes. Besides, areas enriched with CAFs coincided with displaced and discontinuous basement membranes (denoted by the rectangle in Fig. 16CI ), suggesting that CAFs could play a role in basement membrane invasion. Human fibroblasts were isolated from the primary colon tumor tissues of patients, while decellularized mouse mesentery was used to mimic the basement membrane of tumors. The stiffness of basement membranes under different experimental conditions was measured by AFM. AFM topography and stiffness images clearly visualized that basement membranes treated by cancer cells and CAFs became significantly rougher and softer compared with the control group (Fig. 16CII) , which was consistent with the subsequent quantitative analysis of the roughness and stiffness of basement membranes (Fig. 16CIII) . These physical alterations (roughening, softening) of basement membranes were due to the rearrangements of extracellular matrix caused by cancer cells and CAFs, making the basement membranes permissive for cancer cell invasion. Further studies showed that CAF-induced breaching of the basement membranes was not dependent on matrix metalloproteinase. Instead, CAFs stretched and softened the basement membranes to forming gaps through which cancer cells migrated, providing visual evidence for the dynamics of basement membranes in tumor invasion.
VIII. CONCLUSIONS AND PERSPECTIVES
In this paper, we have reviewed the utilization of AFM to investigate physical oncology, with a particular focus on the biomedical applications of AFM in lymphomas as an example. With the use of AFM, diverse types of biophysical information (e.g., structure, mechanics, dynamics) can be revealed at multiple levels (molecular level, cellular level, and tissue level), as graphically summarized in Fig. 17 . The achievements of AFM in the characterization of physical oncology demonstrate the indicative role of biophysics in tumor development and therapeutics, greatly improving our understanding of cancers. Besides, AFM studies on the primary samples of clinical cancer patients may be used as the reference for investigating other types of cancers, showing the close links between AFM-based assays and clinical environments and providing novel possibilities for nanomedicine. Nevertheless, it is notable that, for the further progress and biomedical applications of AFM in physical oncology, several issues need to be noted.
A. AFM Cellular Topographical Characterization
AFM cellular topographical characterization needs to be improved. From the AFM images of cells, roughness is calculated to quantitatively characterize the cell surface characteristics. However, a notable point is that the cell membranes of living mammalian are soft, thin (the thickness of lipid bilayer is about ∼5 nm [271] ), and are prone to be deformed by the scanning AFM tip [235] . This causes that the AFM topographical images of living mammalian cells contain many types of information (including cell membranes, cytoskeletons, and so on), which results in the difficulties in accurately interpreting the obtained roughness from the AFM images of living cells. Hence, current studies about utilizing AFM to characterize cell surface roughness are commonly performed on chemically fixed cells [202] , [272] , [273] . After chemical fixation, cells become solid and stiff, which significantly decreases the deformation of cells during AFM scanning and therefore facilitates obtaining the topography of cell surface. However, the process of chemical fixation itself inevitably causes the alterations of cellular structures, which means that the results obtained on fixed cells cannot faithfully reflect the real topography of cell surface. As an alternative way, removing cell membrane patches from living cells and then attaching the patches onto the solid support for the subsequent AFM imaging allows exactly characterize the topographical characteristics of cell membranes. In this case, the topography of the inner face of the cell membrane can also be investigated, which will benefits the topographical studies of cells from one more facet. This method has been used to characterize the cell membrane of erythrocytes [127] , [194] and some types of leukemia cells [274] . Performing investigations on more types of cells, especially comparing the differences in cell membrane topographical characteristics between cancerous cells and their healthy counterparts, will be particularly meaningful for understanding tumorigenesis.
B. AFM Cellular Mechanical Characterization
AFM cellular mechanical characterization needs to be standardized and expanded. Currently, studies about utilizing AFM to investigate the cell mechanics involved in tumor development and invasion are commonly focused on measuring the Young's modulus of tumor cells [11] , [13] , [210] , [213] , [214] .
Notably, the Young's modulus of cells measured by different research groups via AFM sometimes varies widely, for example, the measured Young's modulus values of Jurkat leukemia cells exhibit 10 times difference for different groups [275] , [276] . This is because that the Young's modulus of cells measured by AFM is a relative value which is dependent on many factors, including environmental issues (e.g., temperature [277] , culture medium [278] ), instrumental issues (e.g., tip shape, cantilever spring constant) [133] , experimental parameters (e.g., probe loading rate, indentation depth, cell positions being probed) [136] , [279] , data analysis (e.g., theoretical models selection, contact point determination) [280] , [281] , and so on. Thus, the results are comparable only in cases when all of these conditions are identical. Recently, researchers have developed standardized AFM nanomechanical procedure [282] (involving precise adjustment of AFM optical lever system and prerequisites for force spectroscopy methods) which shows the capabilities of obtaining Young's modulus values of living cells independent of the instrument, laboratory and operator, which will promote the development of AFM-based cellular mechanical assays for wide applications in diverse biological systems. Besides, sometimes using cellular Young's modulus as a sole parameter cannot fully indicate cellular behaviors. For example, several studies have shown that combining cellular Young's modulus together with other mechanical properties (such as cellular adhesion force) [152] [153] [154] , [283] better indicates the metastatic potentials of cancerous cells. Hence, performing investigations about utilizing AFM to simultaneously obtain multiple mechanics of cells involved in tumor development and progression will promote the practical applications of cell mechanics as diagnostic or prognostic markers of cancer progression [284] .
C. AFM Molecular Force Spectroscopy
AFM molecular force recognition and unfolding faces challenges. With the use of single-molecule force recognition spectroscopy, the specific receptors on the cell surface can be located. However, a notable point is the membrane proteins on the cell surface dynamically move in the membrane to ensure the fulfillment of biological functions. Membrane proteins are able to both rotate with the membrane (rotational diffusion) and move laterally within the membrane (lateral diffusion) [271] . Highspeed AFM imaging has directly shown the real-time motion of single membrane proteins in the membrane (membrane proteins significantly change their positions in the time scale of less than one second) [285] . Hence, the spatiotemporal heterogeneity of membrane proteins cause the fact that the results probed by AFM single-molecule force recognition spectroscopy can only reflect the distributions of membrane proteins at a particular time point. Performing continuous measurements on the cell surface will benefit understanding the motional dynamics of membrane proteins on the cell surface. Nevertheless, a key issue is that during the experiments, the functionalized tip may rapidly lose biosensitive activities due to tip damage or contamination (e.g., the influence of macromolacules in the medium) [96] . So far during experiments the operator does not know whether the tip has lost activities or remain active, and therefore using an inactive tip to perform measurements can inevitably introduce artificial errors. Hence, for AFM molecular force recognition spectroscopy, developing elaborate and reliable protocols [62] , [183] , [156] for inhibiting the problem of tip contamination will be of great significance for single-molecule studies. Besides, for single-molecule unfolding, current studies are commonly focused on purified molecules [170] , [172] , [286] , [287] , [288] . For living cells, there are many different types of molecules distributed heterogeneously on the cell surface and therefore it is difficult to exactly unfold single specific membrane proteins with unfunctionalized tip. In 2009, Alsteens et al [289] have used functionalized tip to successfully unfold single membrane proteins on living microbial cells, indicating the feasibility of directly unfolding single biomolecules on cell surface. However, at present studies about unfolding single membrane proteins on living mammalian cells are still scarce. Performing researches on more types of cells, especially on cancerous cells and their normal counterparts, will provide novel insights into the role of molecular mechanics in tumor development and progression.
D. AFM for Cancer Translational Medicine
So far applying AFM to the clinical cancer diagnosis in practice is still challenging. One of the main limitations of AFM assays is the low throughput. Currently, the process of AFM manipulations is significantly dependent on manual labor of the operator. Under the guidance of optical microscopy, the operator controls the AFM probe to detect one cell, after which the operator controls the AFM probe to detect the next cell [158] , resulting the time-consuming and inefficient AFM assays (<1 cell/10 min [290] ). For practical applications of AFM assays, such as cancer diagnosis, a large number of cells prepared from the clinical cancer patients need to be detected by AFM, which will pose great burden to the operator. Therefore, automating the process of AFM assays will potentially benefit moving AFM detection to practical cancer diagnosis. However, achieving automated AFM manipulations requires overcoming several technical issues, such as automatically delivering cells to AFM, automated data acquirement and analysis [291] . In recent years, the rapid development of microfluidics-based single-cell assays has shown the enormous potentials of microfluidics as a label-free enabling technology [292] , [293] for high-throughput automated cell sorting and isolation. Hence, investigating the integration of AFM detection with microfluidics-based cell isolation will probably contribute to the development of automated AFM assays, which is of active significance for promoting the translational studies of AFM assays in clinical cancer diagnosis.
Practical issues arise when applying AFM to the clinical biopsy samples of cancer patients. Studies in recent years have demonstrated the capabilities of AFM in probing the mechanics of clinical biopsy samples, including blood [130] , [145] , bone marrow [246] , [247] , and surgical tissues [13] , [270] , which is of considerable significance for understanding the indicative role of biophysics (cellular physics, molecular physics, tissue physics) in clinical conditions. For practical applications, the reliability of the detection methods should be verified on many clinical cancer cases. However, tumor is highly heterogeneous and even in the same tumor different cancerous cells often exhibit different metastatic potentials [294] . Hence, the related procedures need to be exactly standardized, for example, how to acquire biopsy sample, how to recognize target cells (e.g., cancerous cells), how to isolate target cells for AFM detection, how to obtain extracellular matrix slices, the dimensions of the slices, and so on. A notable point is maximally attenuating the influence of the sample preparation process on the fidelity of the obtained primary cells or tissues.
Combining AFM methods with biochemical methods to perform assays on the same pathological cells prepared from clinical cancer patients will benefit understanding the behaviors of primary cells. AFM is able to perform physical detections on living cells without pretreatments [295] (e.g., fixation, labeling, staining). Hence, after AFM physical detection, biochemical assays can be performed on the same cells to analyze the biological functions of cells (e.g., invasive and metastatic potentials [220] ), which will provide directly correlation between cell physics and cell functions at the single-cell level from the perspective of near clinical environments. For example, AFM has been extensively combined with diverse optical microscopy techniques [296] , [297] , including optical microscopy, fluorescence microscopy, confocal laser scanning microscopy, stimulated emission depletion microscopy, and total internal reflection fluorescence microscopy. Particularly, recent studies have strikingly demonstrated the combination of AFM manipulations with biochemical assays on the same cells with the use of cell lines cultured in vitro [298] , [299] . Translating the combined assays to analyze the physics and functions of the same cells on clinical primary cells will yield novel insights into cellular physiological and pathological activities, which will promote the biomedical applications of AFM.
Taken together, this review aims to illustrate that AFM characterizations for physical oncology have become highly powerful and multifunctional for nanomedicine. However, there is significant room for advancement. We hope that this review stimulates further researches in the biophysical and biomechanical communities for better understanding tumor development and progression.
